The accumulation of extracellular matrix in the kidney: Consequences on cellular function

Journal of Nephrology

Volumn 18, Issue 3, 2005, Pages 334-340

  Ruiz Torres, María Piedad ^a,c   López Ongil, Susana ^a,c   Griera, Mercedes ^b,c   Díez Marqués, María Luisa ^b,c   Rodríguez Puyol, Manuel ^b,c   Rodríguez Puyol, Diego ^a,c  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c Instituto Reina Sofía   (Spain)

Author keywords

Endothelial cells; Endothelin; Extracellular matrix proteins; Integrin linked kinase; Integrins; Mesangial cells; Nitric oxide; TGF 1

Indexed keywords

AUTACOID; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOKINE; ENDOTHELIN 1; FIBRONECTIN; GROWTH FACTOR; INTEGRIN; INTEGRIN LINKED KINASE; NITRIC OXIDE; PROSTANOID; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

CELL CULTURE; CELL FUNCTION; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DISEASE COURSE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLOMERULUS FILTRATION; HUMAN; KIDNEY CELL; MESANGIUM CELL; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; UMBILICAL VEIN;

ANIMALS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; GLOMERULAR MESANGIUM; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 23144464377     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-9.
2. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983; 23: 647-55.
3. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-9.
4. Zatz R, Meyer TW, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 1985; 82: 5963-7.
5. Meyer TW, Anderson S, Brenner BM. Dietary protein intake and progressive glomerular sclerosis: The role of capillary hypertension and hyperperfusion in the progression of renal disease. Ann Intern Med 1983; 98: 832-8.
6. Lentine K, Wrone EM. New insights into protein intake and progression of renal disease. Curr Opin Nephrol Hypertens 2004; 13: 333-6.
7. Gross ML, Amann K. Progression of renal disease: New insights into risk factors and pathomechanisms. Curr Opin Nephrol Hypertens 2004; 13: 307-12.
8. Hostetter TH, Nath KA. Role of prostaglandins in experimental renal disease. Contrib Nephrol 1989; 75: 13-8.
9. Klahr S, Morrissey J. Progression of chronic renal disease. Am J Kidney Dis 2003; 41: S3-7.
10. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis 1997; 30: 311-33.
11. Klahr S, Morrissey JJ. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int 2000; 75 (suppl): S7-14.
12. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 2004; 24: 354-65.
13. Alfrey AC. Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 1994; 23: 183-7.
14. Gesualdo L, Di Paolo S, Ranieri E, Schena FP. Growth factors and their receptors in the progression of renal damage. Contrib Nephrol 1995; 111: 38-44.
15. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
16. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990; 86: 453-62.
17. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-4.
18. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 1993; 90: 1814-8.
19. Bobik A. Hypertension, transforming growth factor-beta, angiotensin II and kidney disease. J Hypertens 2004; 22: 1265-7.
20. Ruiz-Torres MP, Bosch RJ, O'Valle F, Del Moral RG, Ramirez C, Masseroli M, Perez-Caballero C, Iglesias MC, Rodriguez-Puyol M, Rodriguez-Puyol D. Age-related increase in expression of TGF-beta1 in the rat kidney: Relationship to morphologic changes. J Am Soc Nephrol 1998; 9: 782-91.
21. Ingram AJ, Scholey JW. Stress-responsive signal transduction mechanisms in glomerular cells. Curr Opin Nephrol Hypertens 2000; 9: 49-55.
22. Hishikawa K, Oemar BS, Nakaki T. Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem 2001; 276: 16797-803.
23. Eng E, Ballermarm BJ. Diminished NF-kappaB activation and PDGF-B expression in glomerular endothelial cells subjected to chronic shear stress. Microvasc Res 2003; 65: 137-44.
24. Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest 1995; 95: 1363-9.
25. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491-7.
26. Garnotel R, Monboisse JC, Randoux A, Haye B, Borel JP. The binding of type I collagen to lymphocyte function-associated antigen (LEA) I integrin triggers the respiratory burst of human polymorphonuclear neutrophils. Role of calcium signaling and tyrosine phosphorylation of LFA 1. J Biol Chem 1995; 270: 27495-503.
27. Ruoslahti E, Engvall E. Integrins and vascular extracellular matrix assembly. J Clin Invest 1997; 100 (suppl): S53-6.
28. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-32.
29. Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001; 155: 505-10.
30. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta 2004; 1692: 103-19.
31. Ortega-Velazquez R, Diez-Marques ML, Ruiz-Torres MP, Gonzalez-Rubio M, Rodriguez-Puyol M, Rodriguez Puyol D. Arg-Gly-Asp-Ser (RGDS) peptide stimulates transforming growth factor beta1 transcription and secretion through integrin activation. FASEB J 2003; 17: 1529-31.
32. Ortega-Velazquez R, Gonzalez-Rubio M, Ruiz-Torres MP, Diez-Marques ML, Iglesias MC, Rodriguez-Puyol M, Rodriguez-Puyol D. Collagen I upregulates extracellular matrix gene expression and secretion of TGF-beta 1 by cultured human mesangial cells. Am J Physiol Cell Physiol 2004; 286: C1335-43.
33. Gonzalez-Santiago L, Lopez-Ongil S, Griera M, Rodriguez-Puyol M, Rodriguez-Puyol D. Regulation of endothelin synthesis by extracellular matrix in human endothelial cells. Kidney Int 2002; 62: 537-43.
34. Gonzalez-Santiago L, Lopez-Ongil S, Rodriguez-Puyol M, Rodriguez-Puyol D. Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen. Circ Res 2002; 90: 539-45.